Search

everythinglearnresearchcommunity

for

Search:↓

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

3D bioprinting in plastic surgery could lead to personalized grafts and fewer complications.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Dermal papilla cells can help regrow hair and are promising for hair loss treatments.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.

Baby teeth stem cells can potentially grow organs and treat diseases.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

The arrector pili muscle might play a role in hair loss and needs more research to understand its impact.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.